Häufige Suchbegriffe
Search results
5 results found-
R&D Investor Briefing 2017
Autoimmune conditions Improved target binding Recombinant Fc Multimer - CSL730 CSL / Momenta Collaboration . First-in-class recombinant Fc multimer targeting Fcγ receptors .
https://www.cslbehring.ch/-/media/shared/documents/7/rd-investor-briefing-2017.pdf